Author | Richard R. Furman, MD | OncLive

Author | Richard R. Furman, MD

Articles

Dr. Furman on FDA-Approved BTK Inhibitors in B-Cell Malignancies

June 23, 2020

Video

Richard R. Furman, MD, discusses FDA-approved BTK inhibitors in B-cell malignancies.

Dr. Furman on the Safety of Acalabrutinib in Hematologic Malignancies

June 16, 2020

Video

Richard R. Furman, MD, discusses the safety of acalabrutinib as a monotherapy in hematologic malignancies.

Dr. Furman on Differences Between BTK Inhibitors in B-Cell Malignancies

June 11, 2020

Video

Richard R. Furman, MD, discusses differences among the different available BTK inhibitors for use in patients with B-cell malignancies.

Dr. Furman on Differences Between BTK Inhibitors in B-Cell Malignancies

June 10, 2020

Video

Richard R. Furman, MD, discusses differences among the different available BTK inhibitors for use in patients with B-cell malignancies.

x